Temple University: Clinical Trials

331 trials sponsored by Temple University, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

205 completed, 41 unknown, 31 recruiting, 16 active not recruiting. 181 Not applicable, 46 Phase 2, 23 Phase 4, 17 Phase 1, 16 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable181Completed 120, Unknown 20, Recruiting 15, Active not recruiting 9, Not yet recruiting 8, Withdrawn 4, Terminated 3, Enrolling by invitation 2
Phase 246Completed 28, Unknown 5, Terminated 4, Withdrawn 4, Recruiting 3, Active not recruiting 2
Phase 423Completed 12, Terminated 5, Unknown 3, Withdrawn 3
Phase 117Completed 11, Unknown 4, Not yet recruiting 1, Withdrawn 1
Phase 316Completed 11, Withdrawn 3, Recruiting 1, Unknown 1
Early Phase 11Recruiting 1

Follow Temple University: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Shared Decision Making for Antipsychotic Medications
The Antipsychotic Medication Decision Aid (APM-DA) - Schizophrenia, Schizoaffective Disorder
Not applicableNot yet recruitingNew York State Psychiatric Institute1202027-01-012026-03-30
Pilot Trial Utilizing β-hydroxy-β-methylbutyrate to Lower IGFBP7 Levels in People With ALS
β-hydroxy-β-methylbutyrate (HMB) - Amyotrophic Lateral Sclerosis ALS
Phase 1Not yet recruitingDuke University1002026-12-012026-11-04
Testing a Mobile Health Application to Improve HIV Prevention and Substance Use Treatment Among Women Involved in the Carceral System
Tool to provide re-entry support and improve linkage to healthcare and social services - Substance Abuse, HIV
Not applicableNot yet recruitingTemple University742026-10-202026-09-29
INTEGRATE-RX: Integrating Clinical Pharmacists in HIV Care to Mitigate Last-Mile Challenges and Reduce Cardiovascular Disease Burden
INTEGRATE-RX - HIV, Hypertension
Not applicableNot yet recruitingTemple University4502026-10-012026-07-17
Development and Test of a Communication Skills Training for Transplant Providers - Aims 2 & 3
EPPComm Provider Training - Kidney Disease, Chronic, End Stage Renal Disease
Not applicableNot yet recruitingTemple University702026-09-012026-06-12
Comparing the Impact of Peer Support vs. Staff-Delivered Transportation Interventions for Young Adults With Intellectual and Developmental Disabilities.
Ready to Ride - Standard Delivery, Ready to Ride - Peer Support Delivery - Intellectual Disability, Mild to Moderate, Developmental Disability
Not applicableEnrolling by invitationTemple University3252026-05-212026-09-10
Implementation Facilitation of Exercise is Medicine Greenville
Clinic Implementation Facilitation - Physical Inactivity, Dyslipidemia
Not applicableNot yet recruitingUniversity of South Carolina352026-05-012026-04-02
PMPR and Chlorhexidine on Periodontal Disease and Vascular Function
Chlorhexidine (0.2%) mouthwash, Placebo mouthwash - Periodontal Disease (PD), Cardio Vascular Disease
Not applicableRecruitingMahdi Mutahar302026-01-232026-03-25
Pyloric Sphincter Abnormalities in Patients With Gastroparesis Symptoms
Gastroparesis, Idiopathic Gastric Motility Disorder
RecruitingJohns Hopkins Bloomberg School of Public Health1502026-01-132026-04-03
A Trauma-Informed Intervention for the Newly HIV-Diagnosed
Resilience-Based Intervention for Stress Reduction and HIV-Related Efficacy (RISE), Waitlist control: Text messaging-reminder comparison condition - Stress, HIV Care Loss to Followup
Not applicableNot yet recruitingTemple University802026-01-052025-07-08
Photo-experiencing and Reflective Listening (PEARL) to Promote Healing Engagement for Survivors of Violence
PEARL (Photo-experiencing and Reflective Listening) - Violence and Victimization
Not applicableCompletedTemple University372025-12-012026-10-08
Hyperpolarized Xenon Functional Lung Imaging in COPD Patients Undergoing Targeted Lung Denervation
Functional imaging of the lungs using MagniXene (hyperpolarized xenon-129) MRI - COPD
WithdrawnXemed LLC2025-09-012026-01-20
Prospective Validation of the Novel PVD-B65 Risk Score in Patients With Chronic Lung Disease and Pulmonary Hypertension
Observational Study - Chronic Lung Disease, Pulmonary Hypertension
RecruitingTemple University1002025-09-012025-09-03
Community Mobility Plans: Improving Community Participation Through Travel Interventions for Adolescents and Young Adults With Intellectual and Developmental Disabilities
Community Mobility Planning Process (CMPP) - Intellectual and Developmental Disability
Not applicableActive not recruitingTemple University392025-08-262026-10-08
MILC: A Comprehensive Mobile Application That Addresses the Breastfeeding Challenges of Low-income Hispanic Mothers
MILC application, Usual care - Breastfeeding, Exclusive
Not applicableWithdrawnBenten Technologies, Inc.2025-06-302026-10-16
Sip and Snack Better (SSB) Study: Improving Added Sugar in Adolescents
Sip & Snack Better (SSB) Intervention, Sip & Snack Better (SSB) Tech-Only Comparison - Dietary Habits, Diet, Healthy
Not applicableCompletedTemple University302025-06-242026-05-05
Testing Gene PilotLX With Latinx Cancer Patients
Gene PilotLX - Cancer
Not applicableActive not recruitingFox Chase Cancer Center2392025-05-302026-09-02
Brief Behavioral Sleep Intervention for Obesity Prevention in Primary Care
Optimize Sleep Primary Care (OSPC), Enhanced Usual Care - Obesity, Childhood, Short Sleep
Not applicableRecruitingTemple University502025-05-152026-02-12
Machine Learning to Reduce Hypertension Treatment Clinical Inertia
Predicted uncontrolled BP status (yes/no) at follow up visit, derived using a machine learning algorithm - Hypertension
Not applicableNot yet recruitingTemple University502025-04-252025-04-10
Optimizing the Prehospital Use of Stroke Systems of Care-Reacting to Changing Paradigms-Implementation (OPUS-i)
OPUS-i algorithm - Stroke
Not applicableRecruitingTemple University3602025-04-012026-03-12

Showing 20 of 331. Sign in to see all of them.

Conditions studied

Obesity (26)  ·  Pulmonary Disease, Chronic Obstructive (16)  ·  Diabetes Mellitus (14)  ·  Motor Activity (12)  ·  Overweight (10)  ·  Gastroparesis (9)  ·  Hypertension (8)  ·  Weight Loss (8)  ·  Anxiety Disorders (7)  ·  Diabetes Mellitus, Type 2 (7)  ·  Emphysema (7)  ·  Idiopathic Pulmonary Fibrosis (7)  ·  Feeding Behavior (6)  ·  Neoplasms (6)  ·  Pediatric Obesity (6)

Interventions

Peripheral Blood Stem Cell Transplantation (6)  ·  Cyclophosphamide (5)  ·  Etoposide (5)  ·  Clavulanic Acid (4)  ·  Filgrastim (4)  ·  Radiotherapy (4)  ·  Standard of Care (4)  ·  Therapeutics (4)  ·  Behavior Therapy (3)  ·  Educational Status (3)  ·  Telemedicine (3)  ·  Botulinum Toxins, Type A (2)  ·  Caloric Restriction (2)  ·  Carboplatin (2)  ·  Cisplatin (2)

Countries

United States (304)  ·  Canada (7)  ·  United Kingdom (4)  ·  Australia (3)  ·  Iceland (1)  ·  Ireland (1)  ·  Israel (1)  ·  Italy (1)  ·  Kenya (1)  ·  New Zealand (1)  ·  Romania (1)

Top investigators

Gary D Foster, PhD (7)  ·  Grace X Ma, PhD (6)  ·  Henry Parkman, MD (6)  ·  Henry P Parkman, MD (5)  ·  Jennifer O Fisher, PhD (5)  ·  Gerard J Criner, MD (4)  ·  Jinsup Song, DPM, PhD (4)  ·  Kenneth F. Mangan, MD, FACP (4)  ·  James Hill, PhD (3)  ·  Ryan C Gibbons, MD (3)  ·  Sharon J Herring, MD, MPH (3)  ·  Thomas R. Klumpp, MD (3)  ·  Alan H Maurer, MD (2)  ·  Beth Pfeiffer, PhD (2)  ·  Beth Pfeiffer, PhD, OTR/L, BCP, FAOTA (2)

Results publications

PMID 20920189, PMID 22465313, PMID 25981554, PMID 26896702, PMID 29975735, PMID 10652686, PMID 12161727, PMID 15507794, PMID 15620501, PMID 16168872, PMID 16294989, PMID 16435644, PMID 16443391, PMID 16481828, PMID 16570748, PMID 16640481, PMID 16919322, PMID 17063017, PMID 17332036, PMID 17352592, PMID 17518963, PMID 17585107, PMID 17615014, PMID 17634300, PMID 17675522, PMID 17682259, PMID 18039285, PMID 18070232, PMID 18205641, PMID 18234327, PMID 18254414, PMID 18445798, PMID 18474051, PMID 18594082, PMID 18767507, PMID 19186773, PMID 19192101, PMID 19197261, PMID 19279303, PMID 19329463, PMID 19571052, PMID 19781877, PMID 19786682, PMID 19820280, PMID 19822591, PMID 20080900, PMID 20082927, PMID 20126467, PMID 20368481, PMID 20436354

NIH funding

U01DK073974 (4), U01DK073975 (4), U01DK073983 (4), U01DK074007 (4), U01DK112193 (4), U24DK074008 (4), U01DK074035 (3), U54CA221705 (3), R01AT001103 (2), R01DA055259 (2), R01HL144718 (2), R33AT009991 (2), U54CA153513 (2), 1RC2DA028967 (1), 271201100006I-0-27100007-1 (1)